Assignee
MONTE ROSA THERAPEUTICS INC
US·1 granted patent·16 pending applications·2 citations·filing 2022–2025
Top patents by PatentIndex Score
17 records- 0188US11912682B2Isoindolinone compoundsMONTE ROSA THERAPEUTICS INC·Filed 2023·Granted Feb 27, 2024·2 cites·7 claims
- 0260US2025115582A1Molecular glue degraders and methods of using the sameMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0360US2025171420A1Molecular glue degraders and methods of using the sameMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0460US2025115581A1Substituted piperidines as ck1a degradersMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0560US2024299559A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0659US2024051936A1Isoindolinone compoundsMONTE ROSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0759US2024051937A1Isoindolinone amide compounds useful to treat diseases associated with gspt1MONTE ROSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0857US2024308976A1Compounds that mediate protein degradation and uses thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0957US2024294495A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1056US2024317706A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1156US2024216355A1Pharmaceutical compositions for use in the prevention and treatment of a disease or disorder caused by or associated with one or more premature termination codonsMONTE ROSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1252US2025037790A1Degron and neosubstrate identificationMONTE ROSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1350US2025022533A1Degron identification using neural networksMONTE ROSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1438US2024287573A1E3 ligase fusion proteins for proximity detectionMONTE ROSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1536US2025257048A1Methods of preparing an isoindolinone derivative and crystal forms thereofMONTE ROSA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1635US2024085421A1Methods for the identification of degronsMONTE ROSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1733US2024261274A1Treatment of myc-driven cancers with gspt1 degradersMONTE ROSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MONTE ROSA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →